Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2026-03-01 @ 5:17 PM
Study NCT ID:
NCT02362035
Status:
COMPLETED
Last Update Posted:
2025-12-11
First Post:
2015-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
Sponsor:
Acerta Pharma BV
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Follicular Lymphoma (FL) | View |
| None | CLL | View |
| None | Small Lymphocytic Lymphoma (SLL) | View |
| None | Richter's Syndrome | View |
| None | Mantle Cell Lymphoma (MCL) | View |
| None | Indolent Non Hodgkin Lymphoma | View |
| None | Waldenström Macroglobulinemia | View |
| None | Multiple Myeloma | View |
| None | Hodgkin Lymphoma | View |
| None | Burkitt Lymphoma | View |
| None | Marginal Zone Lymphomas | View |
| None | Mediastinal Large B Cell Lymphoma | View |
| None | Hairy Cell Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Bruton tyrosine kinase inhibitor | View |
| None | Btk | View |
| None | B-Cell Malignancies | View |
| None | Mantle Cell | View |
| None | Multiple Myeloma | View |
| None | CLL | View |
| None | SLL | View |
| None | DLBCL | View |
| None | Follicular | View |
| None | Waldenstrom | View |
| None | Burkitt lymphoma | View |
| None | marginal zone lymphomas | View |
| None | hairy cell leukemia | View |
| None | B cell acute lymphoid leukemia | View |
| None | Acalabrutinib | View |
| None | ACP-196 | View |